|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
9 u- w* b" f i( ~0 ^' X* d3 Dwas to close its brain research facility in Basel, Switzerland,+ l: D* \( N/ K* w$ i
the story noted that this move closely followed similar cuts
# @9 b# M% Y2 j6 O! cby rival pharmaceutical firms. As a report from the European College
0 D% m6 P/ K4 N3 Tof Neuropsychopharmacology
% H. p% a1 Q- Z. Q+ jhad warned a few months earlier, the. Z) t+ D! l d% \1 S3 U! J0 V' v
abandonment of research into new psychiatric drugs by AstraZeneca,& z [) L# U/ ]; p+ U3 G: C: s
GlaxoSmithKline5 W& N+ z6 Q. ]+ `9 @' |3 r5 r
and others meant that “withdrawal of research
/ W- P" j+ l4 H) Mresources is a withdrawal of hope for patients and their families”.: }- ~5 L! D) e1 ]8 G2 Z9 z
5 o6 @& G; S$ U6 Y8 v% @0 Q6 u) x7 G) p3 A
回复有免费下载链接
8 e4 |1 K0 w) E% [& K% O# m; Q
3 v( G E: R; z& T3 k& X+ m) o |
-
总评分: 包包 + 20
查看全部评分
|